 Opiant Pharmaceuticals, Inc. NASDAQ:OPNT Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Ben Atkins - VP Communications and Investor Relations Roger Crystal - President, Chief Executive Officer David OToole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Carl Byrnes - Northland Capital Markets Trevor Allred - Oppenheimer Operator Greetings, and welcome to Opiant Pharmaceuticals Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. 